M Herling Selected Research

tinostamustine

1/2021	Corrections: Reinstated p53 response and high anti-T-cell leukemia activity by the novel alkylating deacetylase inhibitor tinostamustine.
1/2020	Reinstated p53 response and high anti-T-cell leukemia activity by the novel alkylating deacetylase inhibitor tinostamustine.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

M Herling Research Topics

Disease

5	Neoplasms (Cancer) 01/2018 - 07/2000
3	Lymphoma (Lymphomas) 11/2022 - 08/2001
3	Leukemia 01/2021 - 10/2015
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 11/2022 - 08/2012
1	Hematologic Neoplasms (Hematological Malignancy) 11/2022
1	B-Cell Lymphoma (Lymphoma, B Cell) 11/2022
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 11/2022
1	Disease Progression 11/2022
1	Brain Neoplasms (Brain Tumor) 03/2021
1	T-Cell Prolymphocytic Leukemia (Leukemia, T Cell, Chronic) 01/2018
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2016
1	Chromosome Aberrations (Chromosome Abnormalities) 09/2001
1	Hodgkin Disease (Hodgkin's Disease) 09/2001
1	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 08/2001
1	Carcinogenesis 07/2000

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 01/2016 - 07/2000
2	tinostamustineIBA 01/2021 - 01/2020
2	Thomsen-Friedenreich antibodiesIBA 01/2021 - 01/2020
2	Anaplastic Lymphoma KinaseIBA 09/2001 - 08/2001
2	Pyridinolcarbamate (P23)IBA 09/2001 - 08/2001
1	CRISPR-Associated Protein 9IBA 11/2022
1	venetoclaxIBA 11/2022
1	DNA (Deoxyribonucleic Acid)IBA 11/2022
1	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 08/2012
1	Monoclonal AntibodiesIBA 02/2006
1	CarbohydratesIBA 07/2000
1	LectinsIBA 07/2000
1	Biological ProductsIBA 07/2000
1	Glycoproteins (Glycoprotein)IBA 07/2000
1	LigandsIBA 07/2000

Therapy/Procedure

2	Therapeutics 01/2018 - 01/2016
1	Drug Therapy (Chemotherapy) 03/2021
1	Radiotherapy 03/2021